This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Aptose Biosciences Inc.
Drug Names(s): GTI-2040
Description: LOR-2040 is an antisense oligonucleotide that is complementary to a region in the R2 small subunit component of human ribonucleotide reductase.
Additional information available to subscribers only: